BDTX Institutional Ownership
BLACK DIAMOND THERAPEUTICS I
Latest close $1.79 as of Aug 5, 2026
BDTX institutional ownership at a glance
Follow BLACK DIAMOND THERAPEUTICS I institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: BlackRock filed Initial Schedule 13G on Jul 27, 2026, reporting 3.8M shares and 12.00% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 reducing across 1 comparable institution.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 7 filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 27, 2026 filed · 27d Initial Schedule 13G | Initial Schedule 13G | 3.8M | 12.00% | $1.85 | $1.73 | $1.79 |
| T. Rowe Price Investment Management CIK0001897612 | Jun 30, 2026 observed Jul 8, 2026 filed · 8d Schedule 13G amendment | Reported reduction | 4.0M -6.7M | 12.00% -7.00 pts | $1.85 | $1.90 | $1.79 |
| T. Rowe Price Investment Management CIK0001897612 | Sep 30, 2024 observed Nov 14, 2024 filed · 45d Schedule 13G amendment | Reported accumulation | 10.7M +74.7K | 19.00% +0.10 pts | $4.35 | $2.85 | $1.79 |
Related research
Compare BDTX with other securities showing similar institutional activity or recent accumulation across several tracked institutions.